Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differential growth factor expression in transformed mouse NIH-3T3 cells.

F Ciardiello1, E M Valverius, G L Colucci-D'Amato

  • 1Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

Journal of Cellular Biochemistry
|January 1, 1990
PubMed
Summary

Transformed mouse cells express specific growth factor mRNA and proteins, including transforming growth factor-alpha (TGF alpha), TGF beta, and platelet-derived growth factor. This suggests distinct transforming genes control different growth factor sets.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomised study of encorafenib, cetuximab, and FOLFIRI versus FOLFIRI with or without bevacizumab in BRAF V600E-mutant colorectal cancer: BREAKWATER Cohort 3.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

<i>HER-2</i> gene alterations as biomarker in patients with metastatic colorectal cancer treated with FOLFIRI + cetuximab: findings from the CAPRI-2 GOIM study.

ESMO gastrointestinal oncology·2026
Same author

Clinical and translational results from the phase II ABACO trial evaluating the activity of cabozantinib in pretreated patients with metastatic colorectal cancer.

ESMO gastrointestinal oncology·2026
Same author

Off-label drug use in oncology: integrating molecular and genetic analysis in an academic center's real-world approach.

ESMO real world data and digital oncology·2026
Same author

Establishment of the Campania Oncology Network (Rete Oncologica Campana, ROC): a paradigm shift in oncological care and real world research in the Campania region.

ESMO real world data and digital oncology·2026
Same author

Managing adverse events in patients with metastatic colorectal cancer receiving trifluridine/tipiracil in combination with bevacizumab.

ESMO gastrointestinal oncology·2026

Area of Science:

  • Molecular biology
  • Cell biology
  • Oncology

Background:

  • Cell transformation by oncogenes, viruses, or carcinogens alters cellular functions.
  • Growth factors play crucial roles in cell growth, differentiation, and cancer.
  • Understanding growth factor expression in transformed cells is key to cancer research.

Purpose of the Study:

  • To investigate the expression of growth factor-specific mRNA and biologically active growth factors in mouse NIH-3T3 cells transformed by various agents.
  • To determine the relationship between specific oncogenes and the production of different growth factors.
  • To examine the impact of altered growth factor expression on epidermal growth factor receptor levels.

Main Methods:

  • Analysis of mRNA transcripts for various growth factors (TGF alpha, TGF beta, basic FGF, PDGF A and B chains).

Related Experiment Videos

  • Detection and quantification of biologically active growth factors in conditioned medium and cell extracts.
  • Measurement of epidermal growth factor receptor levels on transformed cell surfaces.

    • Main Results:

    • Transformed NIH-3T3 cells, except for SV40-transformed cells, expressed TGF alpha mRNA and secreted active TGF alpha.
    • Elevated TGF alpha levels correlated with a significant reduction in epidermal growth factor receptors.
    • TGF beta, basic FGF, and platelet-derived growth factor (PDGF) variants were detected in specific transformed cell lines, with distinct mRNA expression patterns.

    Conclusions:

    • Different transforming genes are associated with the expression of specific sets of growth factors.
    • Altered growth factor profiles in transformed cells may contribute to their aberrant behavior.
    • The study highlights the complex interplay between genetic alterations and growth factor dysregulation in cancer development.